BCG

GiantLeap Capital Joins Intel Capital and DigitalBridge in Investing in Articul8, a spin-off of Intel's business focused on Enterprise Generative AI

Retrieved on: 
Friday, January 5, 2024
Entrepreneurship, Partnership, Intellectual property, Philosophy, Boston Consulting Group, Data center, Telecommunications, DigitalBridge, Semiconductor, GiantLeap, BCG, Artificial intelligence, IP, Growth, Intel Capital, Partner (business rank), Management

Articul8 provides a comprehensive, vertically-integrated, and secure generative artificial intelligence (GenAI) software platform tailored for enterprise clients, with a choice of cloud, on-prem or hybrid deployment.

Key Points: 
  • Articul8 provides a comprehensive, vertically-integrated, and secure generative artificial intelligence (GenAI) software platform tailored for enterprise clients, with a choice of cloud, on-prem or hybrid deployment.
  • Samir Parikh, Co-Founder and Managing Partner at GiantLeap Capital, said: "This strategic investment, made in collaboration with Intel Capital and DigitalBridge, highlights GiantLeap Capital's differentiated special situations investing strategy in growth equity opportunities in the private and public markets.
  • Alex Villela, Head of DigitalBridge Ventures, said, "Every global enterprise today is challenged to integrate GenAI capabilities into their workflows.
  • We see GenAI as a pivotal force driving digital infrastructure, and we are pleased to collaborate with Intel and GiantLeap Capital to support Articul8's growth."

Vintage Wine Estates Names Ryan Watson as Chief Marketing Officer

Retrieved on: 
Thursday, January 4, 2024
Food, Beverage, Marketing, Wine & Spirits, Retail, Communications, Goldman Sachs, Kraft Heinz, Boston Consulting Group, Princeton University, Multimedia, Partner, Acquisition, CMO, Amazon, Consumer, VWE, AI, BCG, Knowledge, DTC, B2C, Growth, Business analyst, CFA, Sales

Vintage Wine Estates, Inc. (Nasdaq: VWE and VWEWW) (“VWE” or the “Company”), one of the top wine producers in the U.S., today announced the appointment of Ryan Watson as Chief Marketing Officer (“CMO”).

Key Points: 
  • Vintage Wine Estates, Inc. (Nasdaq: VWE and VWEWW) (“VWE” or the “Company”), one of the top wine producers in the U.S., today announced the appointment of Ryan Watson as Chief Marketing Officer (“CMO”).
  • Mr. Watson joins VWE with nearly 20 years’ experience in global, data-driven, consumer-oriented marketing and transformational strategies in both B2B and B2C verticals across a variety of industries.
  • Seth Kaufman, President and Chief Executive Officer, commented, “We are thrilled to welcome Ryan to our executive team to lead our efforts in creating a consumer-focused enterprise that can deliver sustainable growth.
  • Prior to BCG, Mr. Watson had a unique career path spanning Amazon, Kraft Heinz, Tesco, and two high-growth consumer companies.

Leaders Who Prioritize Psychological Safety Can Reduce Attrition Risk to Less than 3% of Workers

Retrieved on: 
Thursday, January 4, 2024
Workforce, Human, Culture, Emotion, BIPOC, Workplace, BCG, Learning, Risk, Employment, Boston Consulting Group, Woman, Disability, Management

BOSTON, Jan. 4, 2024 /PRNewswire/ -- Employees who feel safe to speak up in the workplace and take risks without fear of being blamed or criticized report feeling 2.1 times more motivated, 2.7 times happier, and 3.3 times more enabled to reach their full potential at work. When leaders successfully build this feeling—known as "psychological safety"—among their workforce, attrition risk is greatly reduced.

Key Points: 
  • When leaders successfully build this feeling—known as "psychological safety"—among their workforce, attrition risk is greatly reduced.
  • But when psychological safety is high, only 3% of employees are at risk of quitting.
  • Conversely, in environments where psychological safety is low, members of diversity groups have a higher risk of attrition relative to other employees.
  • By comparison, for those in the top 30% of psychological safety, the attrition risk gap between groups narrows, resulting in a 3% attrition risk for all.

Intel and DigitalBridge Launch Articul8, an Enterprise Generative AI Company

Retrieved on: 
Wednesday, January 3, 2024
Data Management, Communications, Technology, Software, Artificial Intelligence, Hardware, Public Relations, Investor Relations, Ecosystem, Intellectual property, Boston Consulting Group, Multimedia, Credit, Telecommunications, DigitalBridge, Semiconductor, INTC, Intel, Zain Group, HPC, BCG, Artificial intelligence, IP

Intel Corp. (Nasdaq: INTC) and DigitalBridge Group, Inc. (NYSE: DBRG; “DigitalBridge”), a global investment firm, today announced the formation of Articul8 AI, Inc. (Articul8), an independent company offering enterprise customers a full-stack, vertically-optimized and secure generative artificial intelligence (GenAI) software platform.

Key Points: 
  • Intel Corp. (Nasdaq: INTC) and DigitalBridge Group, Inc. (NYSE: DBRG; “DigitalBridge”), a global investment firm, today announced the formation of Articul8 AI, Inc. (Articul8), an independent company offering enterprise customers a full-stack, vertically-optimized and secure generative artificial intelligence (GenAI) software platform.
  • The platform delivers AI capabilities that keep customer data, training and inference within the enterprise security perimeter.
  • View the full release here: https://www.businesswire.com/news/home/20240103045309/en/
    Intel Corp. and DigitalBridge Group Inc. announce the formation of Articul8 AI Inc., an independent company offering enterprise customers a full-stack, vertically-optimized and secure generative artificial intelligence (GenAI) software platform.
  • As Intel accelerates AI everywhere, we look forward to our continued collaboration with Articul8," said Pat Gelsinger, Intel CEO.

MorganFranklin Consulting Named as a Representative Vendor in 2023 Gartner® Market Guide for Supply Chain Strategy, Planning and Operations Consulting

Retrieved on: 
Wednesday, January 3, 2024
McKinsey & Company, Forecasting, Research, Software as a service, Strategic planning, AI, BCG, Cloud computing, Growth, Publication, Platform as a service, Risk management

WASHINGTON, Jan. 3, 2024 /PRNewswire/ -- MorganFranklin Consulting, a leading management and technology advisory firm that specializes in solving complex transformational challenges for its clients, has been recognized as a Representative Vendor in the 2023 Gartner Market Guide for Supply Chain Strategy, Planning and Operations Consulting. This is the third consecutive year MorganFranklin has been named in the guide.

Key Points: 
  • WASHINGTON, Jan. 3, 2024 /PRNewswire/ -- MorganFranklin Consulting , a leading management and technology advisory firm that specializes in solving complex transformational challenges for its clients, has been recognized as a Representative Vendor in the 2023 Gartner Market Guide for Supply Chain Strategy, Planning and Operations Consulting.
  • According to the report, "The supply chain strategy, planning and operations consulting market is responding to market and technology forces.
  • Supply chain leaders can use this Market Guide to find the right consulting firm."
  • Download the full Gartner Market Guide for Supply Chain Strategy, Planning and Operations Consulting here .

QIAGEN expands business in Middle East with new regional headquarters and major projects

Retrieved on: 
Wednesday, January 3, 2024
EEMEA, Workforce, TST, TB, CDC, Policy, QCI, Medicine, Commercial, Infection, Cervical cancer, Marketing, QGEN, QIAGEN, WHO, Disease, HPV, Incidence, Latent tuberculosis, Language interpretation, Vaccination, QDI, BCG, Meningitis, Ministry, Public, World Health Organization, Memorandum of understanding, Patient, Bacteria, Gold

“At QIAGEN, we believe that improving healthcare outcomes starts with a strong foundation of collaboration and innovation, and we are excited to play a crucial role in advancing health and well-being throughout the Middle East.

Key Points: 
  • “At QIAGEN, we believe that improving healthcare outcomes starts with a strong foundation of collaboration and innovation, and we are excited to play a crucial role in advancing health and well-being throughout the Middle East.
  • To accommodate its growing regional presence and customer needs, QIAGEN will inaugurate its new regional headquarters in Riyadh, Saudi Arabia, at the beginning of 2024.
  • This office will further strengthen the company’s commitment to the Middle East and improve its ability to serve clients in the area.
  • The CDC and WHO endorse the use of QuantiFERON-TB Gold Plus in all settings to combat the global TB epidemic.

Rezet, Sleep & Recovery as never approached before

Retrieved on: 
Tuesday, January 2, 2024
Respiration, Fitness, Heart rate, Ballistocardiography, Sleep, Sport, Internet of things, BCG, Massage, System, Relaxation, Bed, Environment, Nursing

It's more than just a mattress topper; it's an intelligent recovery system blending a machine-learning component for dynamic firmness adjustment.

Key Points: 
  • It's more than just a mattress topper; it's an intelligent recovery system blending a machine-learning component for dynamic firmness adjustment.
  • In selected models only, rezet boasts a unique relaxation mode utilizing sound wave therapy, complementing the rejuvenating massage mode that enhances blood circulation and muscle tone for deeper rest and recovery.
  • rezet's capabilities extend to integrating with various IoT devices, including intelligent lifestyle beds and pillows, allowing you to control your environment for an enhanced sleep experience.
  • Embraced by a global community, from individual users to professional sports teams and medical professionals, rezet's technology is a proven catalyst for enhancing sleep and accelerating recovery.

ImmunityBio Announces $320 Million Investment by Oberland Capital, with $210 Million Funded at Closing, Bringing Total Financing in 2023 to $850 Million

Retrieved on: 
Tuesday, January 2, 2024
Biotechnology, Health, Pharmaceutical, Clinical Trials, Oncology, Immunotherapy, Food, Immune system, Jefferies Group, CIS, Bladder cancer, RIPA, FDA, PDUFA, Note, Biologics license application, BCG, Patient, Capital, VWAP, Patrick Soon-Shiong, Food and Drug Administration, Carcinoma in situ, NMIBC, BLA

ImmunityBio, Inc. ( NASDAQ: IBRX ), a clinical-stage immunotherapy company (“ImmunityBio” or the “Company”), today announced an up to $320 million royalty financing and equity investment in the Company by Oberland Capital, with $210 million of gross proceeds received at closing on December 29, 2023.

Key Points: 
  • ImmunityBio, Inc. ( NASDAQ: IBRX ), a clinical-stage immunotherapy company (“ImmunityBio” or the “Company”), today announced an up to $320 million royalty financing and equity investment in the Company by Oberland Capital, with $210 million of gross proceeds received at closing on December 29, 2023.
  • The proceeds will also be used to fund ongoing business operations and clinical trials expanding N-803 (Anktiva®) indications into multiple solid tumors.
  • Oberland Capital has also an option to purchase an additional $10 million of common stock at a future date.
  • Jefferies LLC acted as exclusive financial advisor to the Company on the transaction.

NEC Thailand collaborates with Industrial Estate Authority of Thailand to monitor and manage industrial waste in 14 industrial estates

Retrieved on: 
Friday, November 10, 2023
Carbon, Associate, Industrial park, Risk, Movement, File association, Lung compliance, Health, Industrial waste, Waste management, Legislation, NEC, BCG, Ministry, Safety, Data management, Information technology, Environment

Mr. Ichiro Kurihara, President, NEC Corporation (Thailand) Ltd., said, "NEC designed a comprehensive structure and system to support both public and private industrial sectors.

Key Points: 
  • Mr. Ichiro Kurihara, President, NEC Corporation (Thailand) Ltd., said, "NEC designed a comprehensive structure and system to support both public and private industrial sectors.
  • This system, utilizing cutting-edge technology and NEC's expertise in creating efficient and sustainable waste management systems, enables efficient management and tracking of industrial waste and by-products.
  • Associate Professor Dr. Veeris Ammarapala, Governor, Industrial Estate Authority of Thailand, revealed that the organization has been developing a real-time industrial waste tracking system since 2019.
  • Prof. Dr. Veeris added, "NEC's Real-Time Industrial Waste Tracking System that IEAT is using will further enhance the efficiency of waste tracking and reduce the rate of illegal waste disposal.

Ractigen Therapeutics Advances into Clinical Stage with Groundbreaking saRNA Drug, RAG-01

Retrieved on: 
Wednesday, December 6, 2023
RNA, Bladder cancer, Therapy, Clinical trial, Pharmacokinetics, BCG, SaRNA, RNAa, Patient, Safety, NMIBC, Pharmaceutical industry

JIANGSU, China, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Ractigen Therapeutics, a leader in the field of small activating RNA (saRNA) therapeutics, is excited to announce the submission of a clinical trial application in Australia.

Key Points: 
  • JIANGSU, China, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Ractigen Therapeutics, a leader in the field of small activating RNA (saRNA) therapeutics, is excited to announce the submission of a clinical trial application in Australia.
  • This milestone marks Ractigen's transition into clinical development, with RAG-01 targeting NMIBC.
  • RAG-01 is recognized as the second saRNA drug worldwide to enter clinical trials and the first of its kind in China to achieve this critical milestone.
  • This development signifies a remarkable advancement in RNA-based therapeutic applications, especially in the context of challenging cancer treatments.